Elias Kouchakji
Chief Tech/Sci/R&D Officer bei FIBROGEN, INC.
Profil
Zurzeit bekleidet Elias Kouchakji die Position des Senior VP-Clinical Development & Drug Safety bei FibroGen, Inc. In seiner bisherigen Laufbahn hatte er die Position des Executive Director-Medical & Safety bei Amgen, Inc. inne, Global Head-Pharmacovigilance & Risk Management bei Perrigo Co. Plc und Global Head-Pharmacovigilance & Risk Management bei Elan Pharmaceuticals LLC (eine Tochtergesellschaft von Perrigo Co. Plc), Head-US Safety bei Hoffmann-La Roche, Inc. und Director-Drug Safety & Pharmacovigilance bei EMD Serono, Inc. Elias Kouchakji hat an der Universität Damaskus promoviert.
Aktive Positionen von Elias Kouchakji
| Unternehmen | Position | Beginn |
|---|---|---|
| FIBROGEN, INC. | Chief Tech/Sci/R&D Officer | 01.01.2014 |
Ehemalige bekannte Positionen von Elias Kouchakji
| Unternehmen | Position | Ende |
|---|---|---|
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| PERRIGO COMPANY PLC | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Ausbildung von Elias Kouchakji
| Damascus University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| PERRIGO COMPANY PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
